Glycated Hemoglobin A1C as a Biomarker Predictor for Diabetes Mellitus, Cardiovascular Disease and Inflammation  

Oleh:

Indranila K. S.

Jenis: Article from Journal - ilmiah nasional - terakreditasi DIKTI
Dalam koleksi: Indonesian Journal of Clinical Pathology and Medical Laboratory vol. 23 no. 02 (Mar. 2017), page 191-196.
Topik: HbA1c; Biomarker; Molecular Aspect; DM; CVD; Inflammation
Fulltext: I01 v23 n2 p191 kelik2017.pdf (397.7KB)

Ketersediaan

Perpustakaan FK Nomor Panggil: I01.K Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Glycated Hemoglobin A1c (HbA1c) has been widely recognized as a biomarker predictor for the severity of Diabetes Mellitus (DM). Glycated Hemoglobin (HbA1c) is a pivotal biomarker reflecting both fasting and postprandial plasma glucose concentration over the preceding 120 days. It has been regarded as an important tool in diabetes diagnosis and management. Elevated HbA1c levels probably mean longterm insulin resistance and severe consequences such as hyperglycemia, dyslipidemia, hypercoagulability, and inflammatory response. There is a positive relationship between elevated HbA1c and poor outcome not only in DM, but also Cardiovascular Disease (CVD) and inflammation. It is said that HbA1c is a biomarker predictor in several ways as molecular aspects through hyperglycemic environtment increasing apoptosis of polymorphonuclear leukocytes and production of inflammatory cytokines.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali